Source:http://linkedlifedata.com/resource/pubmed/id/18988708
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-5-21
|
pubmed:abstractText |
The derivation of mesenchymal progenitors from human embryonic stem cells (hESCs) has recently been reported. We studied the immune characteristics of these hESC-derived mesenchymal progenitors (EMPs) and their interactions with T lymphocytes and natural killer cells (NKs), two populations of lymphocytes with important roles in transplantation immunology. EMPs express a number of bone marrow mesenchymal stromal cell (BMMSC) markers, as well as the hESC marker SSEA-4. Immunologically, EMPs do not express HLA-DR or costimulatory molecules. On the other hand, HLA-G, a nonclassic MHC I protein involved in mediating maternal-fetal tolerance, can be found on the surface of EMPs, and its expression is increased after interferon-gamma stimulation. EMPs can suppress CD4(+) or CD8(+) lymphocyte proliferation, similar to BMMSCs. However, EMPs are more resistant to NK-mediated lysis than BMMSCs and can suppress the cytotoxic effects of activated NKs, as well as downregulating the NK-activating receptors NKp30 and NKp46. With their broad immunosuppressive properties, EMPs may represent a new potential cell source for therapeutic use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1549-4918
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
451-6
|
pubmed:meshHeading |
pubmed-meshheading:18988708-Antigens, CD56,
pubmed-meshheading:18988708-Apoptosis,
pubmed-meshheading:18988708-CD4-Positive T-Lymphocytes,
pubmed-meshheading:18988708-CD8-Positive T-Lymphocytes,
pubmed-meshheading:18988708-Cell Line,
pubmed-meshheading:18988708-Cell Proliferation,
pubmed-meshheading:18988708-Cells, Cultured,
pubmed-meshheading:18988708-Embryonic Stem Cells,
pubmed-meshheading:18988708-Humans,
pubmed-meshheading:18988708-Immunophenotyping,
pubmed-meshheading:18988708-Interferon-gamma,
pubmed-meshheading:18988708-Interleukin-15,
pubmed-meshheading:18988708-Interleukin-2,
pubmed-meshheading:18988708-Killer Cells, Natural,
pubmed-meshheading:18988708-Mesenchymal Stem Cells,
pubmed-meshheading:18988708-T-Lymphocytes
|
pubmed:year |
2009
|
pubmed:articleTitle |
Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.
|
pubmed:affiliation |
Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|